Tyra Bioscience Advances Dabogratinib Pipeline, Supporting Unchanged $56 Price Target and Buy Rating
at www.tipranks.com (Fri, 13-Nov 6:45 PM)
Analysts Are Bullish on Top Healthcare Stocks: Claritev (CTEV), Tyra Bioscience (TYRA)
at www.tipranks.com (Thu, 12-Nov 4:10 AM)
Oppenheimer Sticks to Their Buy Rating for Tyra Bioscience (TYRA)
at www.tipranks.com (Wed, 11-Nov 9:05 AM)
Canaccord Genuity Sticks to Their Buy Rating for Tyra Bioscience (TYRA)
at www.tipranks.com (Wed, 11-Nov 9:05 AM)
Tyra Biosciences GAAP EPS of -$0.74 misses by $0.07
at seekingalpha.com (Tue, 10-Nov 8:56 AM)